IL227475A0 - Ethods and kits for assessing heparanase procoagulant acitivity, compositions comprising heparanase, and methods for the treatment of coagulation-related disorders - Google Patents

Ethods and kits for assessing heparanase procoagulant acitivity, compositions comprising heparanase, and methods for the treatment of coagulation-related disorders

Info

Publication number
IL227475A0
IL227475A0 IL227475A IL22747513A IL227475A0 IL 227475 A0 IL227475 A0 IL 227475A0 IL 227475 A IL227475 A IL 227475A IL 22747513 A IL22747513 A IL 22747513A IL 227475 A0 IL227475 A0 IL 227475A0
Authority
IL
Israel
Prior art keywords
heparanase
ethods
acitivity
assessing
coagulation
Prior art date
Application number
IL227475A
Other languages
Hebrew (he)
Original Assignee
Vlodavsky Israel
Health Corp Rambam
Nadir Yona
Brenner Benjamin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2012/000027 external-priority patent/WO2012098542A2/en
Application filed by Vlodavsky Israel, Health Corp Rambam, Nadir Yona, Brenner Benjamin filed Critical Vlodavsky Israel
Priority to IL227475A priority Critical patent/IL227475A0/en
Publication of IL227475A0 publication Critical patent/IL227475A0/en

Links

IL227475A 2011-01-18 2013-07-14 Ethods and kits for assessing heparanase procoagulant acitivity, compositions comprising heparanase, and methods for the treatment of coagulation-related disorders IL227475A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL227475A IL227475A0 (en) 2011-01-18 2013-07-14 Ethods and kits for assessing heparanase procoagulant acitivity, compositions comprising heparanase, and methods for the treatment of coagulation-related disorders

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161433529P 2011-01-18 2011-01-18
US201161551939P 2011-10-27 2011-10-27
PCT/IL2012/000027 WO2012098542A2 (en) 2011-01-18 2012-01-18 Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation-related disorders
IL227475A IL227475A0 (en) 2011-01-18 2013-07-14 Ethods and kits for assessing heparanase procoagulant acitivity, compositions comprising heparanase, and methods for the treatment of coagulation-related disorders

Publications (1)

Publication Number Publication Date
IL227475A0 true IL227475A0 (en) 2013-09-30

Family

ID=49328861

Family Applications (1)

Application Number Title Priority Date Filing Date
IL227475A IL227475A0 (en) 2011-01-18 2013-07-14 Ethods and kits for assessing heparanase procoagulant acitivity, compositions comprising heparanase, and methods for the treatment of coagulation-related disorders

Country Status (1)

Country Link
IL (1) IL227475A0 (en)

Similar Documents

Publication Publication Date Title
IL274469A (en) Compositions, uses and methods for treatment of metabolic disorders and diseases
IL239355A0 (en) Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
EP2675469A4 (en) Compositions, devices and methods of use thereof for the treatment of cancers
EP2847152A4 (en) Compositions and methods for the treatment of metabolic syndrome
EP2714081A4 (en) Methods, compositions, and kits for the treatment of cancer
EP2552433A4 (en) Compositions and methods for the treatment of somatosensory disorders
IL222695A0 (en) Methods, compositions, and kits for the treatment of matrix mineralization disorders
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15- hetre and methods of use thereof dgla15-ohepa/ 15-hetre
HRP20181950T1 (en) Samidorphan (alks 33) in combination with buprenorphine for the treatment of depressive disorders
EP2675478A4 (en) Compositions and methods for the therapy and diagnosis of influenza
EP2696874A4 (en) Compositions and methods for the treatment of nasal conditions
MX351631B (en) Compositions and methods for reducing the incidence of equine digestive disorders.
EP2633047A4 (en) Compositions and methods for the generation of platelets and methods of use thereof
HK1257401A1 (en) Methods and compositions for the treatment of diabetes and related symptoms
EP2643470A4 (en) Compositions and methods for diagnosing and treating diseases and disorders associated with d-dt
EP2665488A4 (en) Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation-related disorders
EP3603631C0 (en) Methods and compositions for the treatment of diverticulosis
EP2673372A4 (en) Methods of prognosing and administering treatment for inflammatory disorders
ZA201408053B (en) Compositions and methods for the treatment of metabolic syndrome
IL227475A0 (en) Ethods and kits for assessing heparanase procoagulant acitivity, compositions comprising heparanase, and methods for the treatment of coagulation-related disorders
GB201107553D0 (en) Composition and methods for the treatment of neuroendocrine and pitutitary tumoars
EP2747785A4 (en) Methods and compositions for the treatment of respiratory conditions via nkg2d inhibition
IL227921A0 (en) Methods of prognosing and administering treatment for inflammatory disorders
AU2011901902A0 (en) Methods and compositions for the treatment of melanoma

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed